Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Research Tools and Instruments - Category 1 (<$150,000)

Université Laval

$148,286.00

Proton relaxation studies and particle size analysis of suspensions of magnetic and radioactive metal colloids

FY 2007-08

Summary
Molecular imaging allows modern medicine to examine the functions of molecules and cells in living organisms. The aim of this proposal is to increase our knowledge regarding the use of metal colloids providing positive contrast in magnetic resonance imaging. Synthesized with gadolinium and manganese, these colloids display huge potential for cell labelling and tracking. The development of contrast agents and tracers (biomarkers) providing high and specific signal in magnetic resonance imaging (MRI) and positron emission tomography (PET) could be advantageously used with a next generation of scanners combining MRI and PET, that will soon become a reality in the clinic. MRI is a non-invasive imaging technique providing high resolution pictures in low density tissues. Magnetic molecules or nanoparticles are often necessary to finely delineate the vasculature, to precisely identify disease artefacts, and to track cells. PET is also a non-invasive imaging technique, based on the detection at very high sensitivity, of radioactive tracers. Magnetic metal colloids in the form of nanoparticles can be used to improve the specificity of the MRI signal. By doping these crystalline "nanomaterials" with carefully selected radioactive atoms, a next generation of biomarkers could become available for dual PET/MRI procedures. The physico-chemical characterization of magnetic metal colloids for MRI requires the use of a fast and accurate technique for measuring the hydrodynamic radius of the nanoparticles suspended in fluids. Then, by measuring the zeta potential, it is possible to evaluate the tendency of the particles to aggregate. Finally, the potential of the contrast agent to generate strong contrast effects in MRI pictures, can be precisely measured at varying temperatures with a dedicated relaxometer (measurement of proton relaxation times). NMR proton relaxation analyzers can also be used to measure the contrast generated by suspensions of cells marked with magnetic tracers. The combined use of these technologies are crucial for the  development of magnetic and radioactive tracers for dual PET/MRI.
Program
Research Tools and Instruments - Category 1 (<$150,000)
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
359692-2008
Name nom
Fortin, MarcAndré
Department département
Génie des mines, métallurgie et matériaux
Organization id
51
Institution établissement
Université Laval
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2007
Competition year année de concours
2008
Award amount
148286
Program id
EQPEQ
Program name en
Research Tools and Instruments - Category 1 (<$150,000)
Program name fr
Outils et instruments de recherche - catégorie 1 (<150 000$)
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
4
Committee name en
Chem. & Metallurgical Eng.
Committee name fr
Génies chimique et métal.
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1902
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical materials
Research subject fr
Matériaux biomédicaux
Partie
1
Nb partie
1
Application title
Proton relaxation studies and particle size analysis of suspensions of magnetic and radioactive metal colloids
Keyword
NA
Application summary
Molecular imaging allows modern medicine to examine the functions of molecules and cells in living organisms. The aim of this proposal is to increase our knowledge regarding the use of metal colloids providing positive contrast in magnetic resonance imaging. Synthesized with gadolinium and manganese, these colloids display huge potential for cell labelling and tracking. The development of contrast agents and tracers (biomarkers) providing high and specific signal in magnetic resonance imaging (MRI) and positron emission tomography (PET) could be advantageously used with a next generation of scanners combining MRI and PET, that will soon become a reality in the clinic. MRI is a non-invasive imaging technique providing high resolution pictures in low density tissues. Magnetic molecules or nanoparticles are often necessary to finely delineate the vasculature, to precisely identify disease artefacts, and to track cells. PET is also a non-invasive imaging technique, based on the detection at very high sensitivity, of radioactive tracers. Magnetic metal colloids in the form of nanoparticles can be used to improve the specificity of the MRI signal. By doping these crystalline "nanomaterials" with carefully selected radioactive atoms, a next generation of biomarkers could become available for dual PET/MRI procedures. The physico-chemical characterization of magnetic metal colloids for MRI requires the use of a fast and accurate technique for measuring the hydrodynamic radius of the nanoparticles suspended in fluids. Then, by measuring the zeta potential, it is possible to evaluate the tendency of the particles to aggregate. Finally, the potential of the contrast agent to generate strong contrast effects in MRI pictures, can be precisely measured at varying temperatures with a dedicated relaxometer (measurement of proton relaxation times). NMR proton relaxation analyzers can also be used to measure the contrast generated by suspensions of cells marked with magnetic tracers. The combined use of these technologies are crucial for the  development of magnetic and radioactive tracers for dual PET/MRI.
Université Laval - $148,286 Grant (2007-08) | Canada Spends